clofibrate has been researched along with 2,3-diphosphoglycerate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alliet, KL; Macler, LM; Siemann, DW | 1 |
| Perutz, MF; Poyart, C | 1 |
2 other study(ies) available for clofibrate and 2,3-diphosphoglycerate
| Article | Year |
|---|---|
Manipulations in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy.
Topics: 2,3-Diphosphoglycerate; Animals; Blood Preservation; Clofibrate; Diphosphoglyceric Acids; Erythrocyte Transfusion; Erythrocytes; Mice; Mice, Inbred C3H; Oxygen; Oxyhemoglobins; Radiation Tolerance; Sarcoma, Experimental | 1989 |
Bezafibrate lowers oxygen affinity of haemoglobin.
Topics: 2,3-Diphosphoglycerate; Anemia, Sickle Cell; Bezafibrate; Clofibrate; Diphosphoglyceric Acids; Drug Synergism; Erythrocytes; Hemoglobin A; Hemoglobin, Sickle; Humans; Oxygen; Solubility | 1983 |